| Patents for C07D 471 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups (64,559) |
|---|
| 09/02/2004 | DE10307142A1 Substituierte N-Aryl-Stickstoffheterocyclen Substituted N-aryl nitrogen heterocycles |
| 09/02/2004 | CA2516590A1 Substituted n-aryl nitrogen heterocycles |
| 09/02/2004 | CA2516475A1 Oxazole-derivatives as ppar agonists |
| 09/02/2004 | CA2516235A1 Inhibitors of hepatitis c virus rna-dependent rna polymerase, and compositions and treatments using the same |
| 09/02/2004 | CA2516234A1 N-heterocyclyl-substituted amino-thiazole derivatives as protein kinase inhibitors |
| 09/02/2004 | CA2515939A1 Novel compounds |
| 09/02/2004 | CA2515777A1 Biphenyl derivatives |
| 09/02/2004 | CA2515571A1 Heterocyclyl-3-sulfonylazaindole or -azaindazole derivatives as 5-hydroxytryptamine-6 ligands |
| 09/02/2004 | CA2514908A1 Substituted amino heterocycles as vr-1 antagonists for treating pain |
| 09/02/2004 | CA2514374A1 Deazaflavin compounds and methods of use thereof |
| 09/02/2004 | CA2512928A1 The enantiomer of tenatoprazole and the use thereof in therapy |
| 09/01/2004 | EP1452534A1 Pleuromutlin derivatives as antimicrobials |
| 09/01/2004 | EP1452528A1 Xanthine oxidase inhibitors |
| 09/01/2004 | EP1452527A1 Azabicyclo compound, matrix metalloprotease inhibitor, and skin preparation |
| 09/01/2004 | EP1452525A1 Amide derivatives and drugs |
| 09/01/2004 | EP1451202A1 Aryl fused azapolycyclic compounds |
| 09/01/2004 | EP1451196A1 The use of anti-histaminics for acute reduction of elevated intracranial pressure |
| 09/01/2004 | EP1451191A1 Thioether substituted imidazoquinolines |
| 09/01/2004 | EP1451190A1 Triazolo(4,3-a)pyrido(2,3-d)pyrimidin-5-one derivatives, compositions containing same, preparation method and use thereof |
| 09/01/2004 | EP1451189A1 4-(1,3,4-thiadiazol-2-yl)-1,4-diazabicyclo- 3.2.2]nonane derivatives, preparation and therapeutic use thereof |
| 09/01/2004 | EP1451188A1 4-(oxadiazol-3-yl)-1,4-diazabicyclo 3.2.2]-nonane derivatives, preparation and therapeutic use thereof |
| 09/01/2004 | EP1451187A1 Amide substituted imidazopyridines |
| 09/01/2004 | EP1451186A2 Urea substituted imidazopyridines |
| 09/01/2004 | EP1451167A1 Phenylalkynes |
| 09/01/2004 | EP1451164A2 Amide derivatives having improved solubility |
| 09/01/2004 | EP1451161A1 Imidazopyridines, pyrimidines and triazines for enhancing cognition as gaba-a alpha 5 receptor subtype ligands |
| 09/01/2004 | EP1450801A2 2-aminoquinoline compounds |
| 09/01/2004 | EP1450800A2 SUBSTITUTED AMINO METHYL FACTOR Xa INHIBITORS |
| 09/01/2004 | EP1127058B1 Pyrazolopyridine derivatives as selective cox-2 inhibitors |
| 09/01/2004 | CN1525975A Tert. alkylphenoxy substituted polycyclic compounds |
| 09/01/2004 | CN1525974A Derivatives of triazolyl-imidazopyridine and of the triazolylpurines useful as ligands of the adenosine A2a receptor and their use as medicaments |
| 09/01/2004 | CN1525973A Dihydroimidazo[5,1-a]-beta-carboline derivatives, method for preparing same and use thereof as medicine |
| 09/01/2004 | CN1525972A Hetero-bicyclic crf antagonists |
| 09/01/2004 | CN1525968A Compositions for prevention or treatment of hepatopathy |
| 09/01/2004 | CN1525960A Lorenz Gisela |
| 09/01/2004 | CN1524857A Tartrate salt of a substituted dipeptide as growth hormone secretagogue |
| 09/01/2004 | CN1164591C Hydrated forms of zilpatherol hydrochloride |
| 08/31/2004 | US6784301 Perylene-derivative based crystallization modifiers |
| 08/31/2004 | US6784293 Solution and solid-phase synthesis of boc-protected 3-aminohydantoins/thiohydantoins and 3-aminodihydrouracils/ dihydrothiouracils |
| 08/31/2004 | US6784195 Extracellular signal regulated kinase (erk); anticancer agents and protein kinase inhibitors |
| 08/31/2004 | US6784190 Integrin receptor antagonists |
| 08/31/2004 | US6784188 Urea substituted imidazoquinolines |
| 08/31/2004 | US6784179 Tetracyclic derivatives, process of preparation and use |
| 08/31/2004 | US6784174 Inhibitors of the production of cytokines such as tnf |
| 08/31/2004 | US6783753 Rapidly produces peak plasma concentrations of the compound. |
| 08/26/2004 | WO2004072083A1 Benzamide derivatives as oxytocin agonists and vasopressin antagonists |
| 08/26/2004 | WO2004072074A1 Pyrrolidinohydrochinazolines |
| 08/26/2004 | WO2004072072A1 Triazolo-pyridines as anti-inflammatory compounds |
| 08/26/2004 | WO2004072033A2 Pyrazoles and methods of making and using the same |
| 08/26/2004 | WO2004071460A2 Cyclic derivatives as modulators of chemokine receptor activity |
| 08/26/2004 | WO2004071445A2 2-(aminomethyl)arylamide analgesics |
| 08/26/2004 | WO2004055163A3 Substituted 1-benzoyl-3-cyano-pyrrolo[1,2-a]quinolines |
| 08/26/2004 | WO2004052288A3 2-nh-heteroarylimidazoles with antibacterial activity |
| 08/26/2004 | WO2004050610A3 Modulators of melanocortin receptor |
| 08/26/2004 | WO2004024897A3 PHENYL-AZA-BENZIMIDAZOLE COMPOUNDS FOR MODULATING IgE AND INHIBITING CELLULAR PROLIFERATION |
| 08/26/2004 | WO2004017922B1 Keto cannabinoids with therapeutic indications |
| 08/26/2004 | WO2004000800A3 Electrochromic salts, solutions, and devices |
| 08/26/2004 | US20040167336 Octahydro-indolizine and quinolizine and hexahydro-pyrrolizine |
| 08/26/2004 | US20040167335 For therapy and prophylaxis of herpes viral infections |
| 08/26/2004 | US20040167332 Boronic ester and acid compounds, synthesis and uses |
| 08/26/2004 | US20040167228 aerosols containing atenolol, pindolol, esmolol, propranolol, or metoprolol that are used in inhalation therapy |
| 08/26/2004 | US20040167198 Vasculostatic agents and methods of use thereof |
| 08/26/2004 | US20040167167 Biphenyl derivatives |
| 08/26/2004 | US20040167160 Skin disorders; controlling cell differentiation; antidiabetic agents; cardiovascular disorders; anticancer agents; central nervous system disorders |
| 08/26/2004 | US20040167158 Heterocyclic compounds for the treatment of migraine |
| 08/26/2004 | US20040167156 CCR-2 modulators; INFLAMMATORY, IMMUNOREGULATORY, ALLERGIC, AND AUTOIMMUNE DISORDERS AND DISEASES |
| 08/26/2004 | US20040167154 Urea substituted imidazoquinolines |
| 08/26/2004 | US20040167145 moderator of cholinergic agent; mixture of acetylcholinesterase inhibitors and opioiod receptor blockers |
| 08/26/2004 | US20040167141 Anticancer agents; antidiabetic agents; Alzheimer's disease |
| 08/26/2004 | US20040167138 Antiischemic agents; brain disorders |
| 08/26/2004 | US20040167124 Viricides; immunology moderator |
| 08/26/2004 | US20040167123 Anti-infective agents |
| 08/26/2004 | US20040167121 Indazolinone compositions useful as kinase inhibitors |
| 08/26/2004 | US20040167120 Novel Pyrimidine-4,6-dicarboxylic acid diamides for selectively inhibiting collagenases |
| 08/26/2004 | US20040167119 2-(aminomethyl) arylamide analgesics |
| 08/26/2004 | US20040167106 Prevention of ovarian cancer by administration of a Vitamin D compound |
| 08/26/2004 | US20040167031 Arylphenyl-substituted cyclic ketoenols |
| 08/26/2004 | US20040167030 Heterocyclyl-3-sulfonylazaindole or-azaindazole derivatives as 5-hydroxytryptamine-6 ligands |
| 08/26/2004 | US20040166137 Prevention membrane fusion, transmission of virus; respiratory syncytial virus |
| 08/26/2004 | DE10247271A1 Use of new and known 7-(methyl or trifluoromethyl)-imidazo-(1,2-a)-pyridines as nitrogen monoxide synthase inhibitors useful e.g. for treating migraine, neurodegenerative diseases, inflammatory pain, diabetes or cancer |
| 08/26/2004 | CA2515190A1 Triazolo-pyridines as anti-inflammatory compounds |
| 08/26/2004 | CA2514382A1 Pyrazoles and methods of making and using the same |
| 08/26/2004 | CA2513220A1 Benzamide derivatives as oxytocin agonists and vasopressin antagonists |
| 08/25/2004 | EP1449844A1 benzamide derivatives as oxytocin agonists and vasopressin antagonists |
| 08/25/2004 | EP1449842A1 Process for the preparation of pyrazolopyridine tartrates |
| 08/25/2004 | EP1449835A2 Alpha-substituted pyrimidine-thioalkyl and alkylether compounds |
| 08/25/2004 | EP1449529A1 Protein Kinase C Inhibitors |
| 08/25/2004 | EP1448566A2 Chemokine receptor antagonists and methods of use thereof |
| 08/25/2004 | EP1448564A2 Substituted indolizine-like compounds and methods of use |
| 08/25/2004 | EP1448562A1 Substituted tetracyclic pyrroloquinolone derivatives useful as phosphodiesterase inhibitors |
| 08/25/2004 | EP1448561A1 Beta 3 adrenergic agonists |
| 08/25/2004 | EP1448560A1 3-SUBSTITUTED OXINDOLE $g(b)3 AGONISTS |
| 08/25/2004 | EP1448553A1 N-heterocyclyl hydrazides as neurotrophic agents |
| 08/25/2004 | EP1448542A1 6-hydroxy isoflavones, derivatives and medicaments involving same |
| 08/25/2004 | EP1448539A1 Hiv protease inhibitors, compositions containing the same, their pharmaceutical uses and materials for their synthesis |
| 08/25/2004 | EP1448534A1 6-membered unsaturated heterocyclic compounds useful for selective inhibition ofthe coagulation cascade |
| 08/25/2004 | EP1448525A1 Novel piperidine derivatives as modulators of chemokine receptors |
| 08/25/2004 | EP1448202A1 Combination of a pde4 or pde3/4 inhibitor and an anti-rheumatic drug |
| 08/25/2004 | EP1366048B1 Pyrazolopyridine derivatives |
| 08/25/2004 | EP1353920B1 Process for preparing a substantially pure gamma phase quinacridone pigment of large particle size |